AllianceBernstein’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-68,778
| Closed | -$4.67M | – | 3187 |
|
|
2019
Q3 | $4.67M | Sell |
68,778
-3,208
| -4% | -$220K | ﹤0.01% | 1425 |
|
|
2019
Q2 | $4.19M | Buy |
71,986
+9,900
| +16% | +$586K | ﹤0.01% | 1535 |
|
|
2019
Q1 | $4.35M | Buy |
62,086
+2,200
| +4% | +$163K | ﹤0.01% | 1451 |
|
|
2018
Q4 | $3.86M | Buy |
59,886
+21,541
| +56% | +$1.51M | ﹤0.01% | 1441 |
|
|
2018
Q3 | $2.69M | Buy |
38,345
+400
| +1% | +$23.4K | ﹤0.01% | 1736 |
|
|
2018
Q2 | $1.91M | Sell |
37,945
-89,940
| -70% | -$3.57M | ﹤0.01% | 1953 |
|
|
2018
Q1 | $4M | Buy |
127,885
+90,000
| +238% | +$2.99M | ﹤0.01% | 1343 |
|
|
2017
Q4 | $1.3M | Sell |
37,885
-37,270
| -50% | -$1.19M | ﹤0.01% | 2127 |
|
|
2017
Q3 | $2.41M | Hold |
75,155
| – | – | ﹤0.01% | 1717 |
|
|
2017
Q2 | $2.45M | Sell |
75,155
-16,950
| -18% | -$537K | ﹤0.01% | 1697 |
|
|
2017
Q1 | $2.9M | Sell |
92,105
-46,440
| -34% | -$1.37M | ﹤0.01% | 1544 |
|
|
2016
Q4 | $4.07M | Buy |
138,545
+48,920
| +55% | +$1.49M | ﹤0.01% | 1323 |
|
|
2016
Q3 | $2.59M | Buy |
89,625
+29,080
| +48% | +$810K | ﹤0.01% | 1583 |
|
|
2016
Q2 | $1.57M | Buy |
60,545
+24,960
| +70% | +$663K | ﹤0.01% | 1913 |
|
|
2016
Q1 | $881K | Hold |
35,585
| – | – | ﹤0.01% | 2172 |
|
|
2015
Q4 | $1.25M | Sell |
35,585
-900
| -2% | -$24.1K | ﹤0.01% | 1986 |
|
|
2015
Q3 | $772K | Buy |
36,485
+1,040
| +3% | +$26.8K | ﹤0.01% | 2297 |
|
|
2015
Q2 | $985K | Hold |
35,445
| – | – | ﹤0.01% | 2290 |
|
|
2015
Q1 | $1.08M | Hold |
35,445
| – | – | ﹤0.01% | 2145 |
|
|
2014
Q4 | $1.13M | Hold |
35,445
| – | – | ﹤0.01% | 2136 |
|
|
2014
Q3 | $1M | Sell |
35,445
-3,000
| -8% | -$83.6K | ﹤0.01% | 2203 |
|
|
2014
Q2 | $1.05M | Sell |
38,445
-1,695
| -4% | -$45.1K | ﹤0.01% | 2220 |
|
|
2014
Q1 | $1.06M | Sell |
40,140
-1,872
| -4% | -$53.7K | ﹤0.01% | 2137 |
|
|
2013
Q4 | $1.23M | Sell |
42,012
-3,461
| -8% | -$110K | ﹤0.01% | 2042 |
|
|
2013
Q3 | $1.39M | Sell |
45,473
-374
| -0.8% | -$12.5K | ﹤0.01% | 1942 |
|
|
2013
Q2 | $1.45M | Buy |
+45,847
| New | +$1.51M | ﹤0.01% | 1845 |
|
AllianceBernstein's GHDX Position: Q4 2019 in Review
AllianceBernstein sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 68,778 shares — an estimated $4.67M sold.
AllianceBernstein first reported a position in GHDX in Q2 2013 and held it in 26 quarters. The position peaked at $4.67M in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.
- AllianceBernstein reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
- AllianceBernstein sold 68,778 Genomic Health, Inc. shares in Q4 2019, an estimated $4.67M.
- AllianceBernstein first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 26 quarters.
- AllianceBernstein's Genomic Health, Inc. position peaked at $4.67M in Q3 2019.
- 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.
Based on AllianceBernstein's 13F filing for Q4 2019, filed 18 Feb 2020.